Effecting New Antibiotics, Part II: Microbial Genomics
This article was originally published in Start Up
Executive Summary
The emerging science of microbial genomics is propelling an array of corporate efforts to develop novel antibiotics effective against drug-resistant organisms. Firms compiling genomic databases have been the first to profit, but competition is dropping the price of access.